Medicalip Co., Ltd.
USPTO PatentsView assignee record - 113 granted patents across 30 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Medicalip ranks #3,307 of 49,997 tracked US assignees by granted-patent volume, with 113 patents across 30 technology areas.
- #3,307
- of 49,997 US assignees by volume
- Top 8%
- by Innovation Score (53.8/100)
- 19.0
- avg claims per patent
- -2%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3307 · Foreign Corporation #3,307 · 113 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MID 113 grants
- TOP-DECILE #3,307/49,997
- PHOTO-FINISH Georgia State…
- CPC-FOCUS A61F · 30 areas
- INNOV-PAR 53.8/100
- CLAIMS-RICH 19.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT -2% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Georgia State University Research Foundation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Medicalip’s 53.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Medicalip
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Darktrace Holdings · near
Darktrace Holdings · near
54 score
- International… · near
International… · near
54 score
- Medicalip · this assignee
Medicalip · this assignee
54 score
- Instituto Mexicano… · near
Instituto Mexicano… · near
54 score
- Samsung Life Public… · near
Samsung Life Public… · near
54 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Medicalip's Innovation Score is 53.8/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Medicalip?
Each dot is one of Medicalip’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medicalip’s own 19.0 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Medicalip's grants concentrate
Medicalip Co., Ltd. is a focused PatentsView assignee: 30 CPC subclasses with 27.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (18 grants) versus a trough of 5 in 2018. By volume, Medicalip sits between Golba LLC and Rothy's, Inc.
Medicalip's three-year grant acceleration
From 2019–2021 to 2022–2024, Medicalip Co., Ltd. moved from 36 to 36 grants (1.00x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,166. See the growth leaderboard.
Who files at Medicalip's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Golba
Golba LLC
113 patents
- Georgia State Uni…
Georgia State University Research Foundation
113 patents
- Idemia France
Idemia France
113 patents
- Kanzaki Kokyukoki…
Kanzaki Kokyukoki MFG. Co., Ltd.
113 patents
- Mikuni
Mikuni Corporation
113 patents
- Panasonic I-pro S…
Panasonic I-pro Sensing Solutions Co., Ltd.
113 patents
- Pass & Seymour
Pass & Seymour, Inc.
113 patents
- Rothy's
Rothy's, Inc
113 patents
- Medicalip ◀
Medicalip Co., Ltd.
113 patents
What this shows Medicalip holds 113 patents at rank #3,307, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Medicalip
By rank, the assignees closest to #3,307 in granted patent volume.
- Golba LLC #3,303 · 113 patents
- Georgia State University Research Foundation #3,304 · 113 patents
- Idemia France #3,305 · 113 patents
- Kanzaki Kokyukoki MFG. Co., Ltd. #3,306 · 113 patents
- Mikuni Corporation #3,308 · 113 patents
- Panasonic I-pro Sensing Solutions Co., Ltd. #3,309 · 113 patents
- Pass & Seymour, Inc. #3,310 · 113 patents
- Rothy's, Inc #3,311 · 113 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Medicalip's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Medicalip, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Medicalip ranks #209 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (54 here).
Similar claim depth
Nearest assignees by average claims per patent (19.0 here).
Medicalip's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 11 | 9.7% |
| 2016 | 8 | 7.1% |
| 2017 | 13 | 11.5% |
| 2018 | 5 | 4.4% |
| 2019 | 18 | 15.9% |
| 2020 | 6 | 5.3% |
| 2021 | 12 | 10.6% |
| 2022 | 13 | 11.5% |
| 2023 | 17 | 15.0% |
| 2024 | 6 | 5.3% |
| 2025partial year | 4 | 3.5% |
Which technologies does Medicalip Co., Ltd. patent most?
Top 15 of 30 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Medicalip Co., Ltd.'s patent record in context - here's where to go next.
- Medicalip Co., Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 27.4% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #3,307 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Medicalip Co., Ltd. against Golba LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.